(Q40967567)

English

Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone

scientific article published on April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone (English)

1 reference

Europe PubMed Central

25 September 2017

author name string

S K Manna

1

1 reference

Europe PubMed Central

25 September 2017

Y P Gad

2

1 reference

Europe PubMed Central

25 September 2017

A Mukhopadhyay

3

1 reference

Europe PubMed Central

25 September 2017

B B Aggarwal

4

1 reference

Europe PubMed Central

25 September 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

25 September 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

25 September 2017

57

1 reference

Europe PubMed Central

25 September 2017

7

1 reference

Europe PubMed Central

25 September 2017

763-774

1 reference

Europe PubMed Central

25 September 2017

beta-Lapachone, an inhibitor of oncornavirus reverse transcriptase and eukaryotic DNA polymerase-alpha. Inhibitory effect, thiol dependence and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Activate NF-kappa B or die?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

The regulation of AP-1 activity by mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

NF-κB-mediated Induction ofmdr1bExpression by Insulin in Rat Hepatoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

.beta.-Lapachone: synthesis of derivatives and activities in tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Lipid peroxidation is involved in the activation of NF-kappaB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. Lack of involvement of H2O2 in NF-kappaB activation by either cytokine in both primary and transf

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

NF-kappaB activation: the I kappaB kinase revealed?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Oxidative stress as a mediator of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Redox cycling of beta-lapachone and related o-naphthoquinones in the presence of dihydrolipoamide and oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factor kappa B activation by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

Evaluation of the toxicity of 3-allyl-beta-lapachone against Trypanosoma cruzi bloodstream forms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900354-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(98)00354-2

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40967567&oldid=2099092847"